Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study

Tranexamic acid (TXA) has been used orally, intravenously, topically and intradermally (microinjection, microneedling) for treating melasma. However, the comparative efficacy of these different routes of administration remains underevaluated.

[1]  M. Timalsina,et al.  Oral tranexamic acid for the treatment of melasma , 2018, Clincal and Experimental Dermatology.

[2]  R. Naseem,et al.  Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study , 2016 .

[3]  S. Chang,et al.  Inflammatory features of melasma lesions in Asian skin , 2014, The Journal of dermatology.

[4]  V. Mahajan,et al.  Cosmetic Contact Sensitivity in Patients with Melasma: Results of a Pilot Study , 2014, Dermatology research and practice.

[5]  Mira Choi,et al.  Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser , 2013, The Journal of dermatological treatment.

[6]  J. Na,et al.  Effect of tranexamic acid on melasma: a clinical trial with histological evaluation , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  L. Budamakuntla,et al.  A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma , 2013, Journal of cutaneous and aesthetic surgery.

[8]  J. H. Lee,et al.  Oral Tranexamic Acid Enhances the Efficacy of Low‐Fluence 1064‐Nm Quality‐Switched Neodymium‐Doped Yttrium Aluminum Garnet Laser Treatment for Melasma in Koreans: A Randomized, Prospective Trial , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  E. Hui,et al.  Tranexamic acid: an important adjuvant in the treatment of melasma , 2013, Journal of cosmetic dermatology.

[10]  Yi Sun,et al.  Treatment of Melasma With Oral Administration of Tranexamic Acid , 2012, Aesthetic Plastic Surgery.

[11]  A. Manosroi,et al.  Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial , 2012, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[12]  S. Rathi,et al.  MELASMA: A CLINICO-EPIDEMIOLOGICAL STUDY OF 312 CASES , 2011, Indian journal of dermatology.

[13]  C. Guinot,et al.  Aggravating factors for melasma: a prospective study in 197 Tunisian patients , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  P. Puri,et al.  Melasma in men: a clinical, aetiological and histological study , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  S. Feldman,et al.  The prevalence of melasma and its association with quality of life in adult male Latino migrant workers , 2009, International journal of dermatology.

[16]  B. Khaitan,et al.  Pigmentary disorders in India. , 2007, Dermatologic clinics.

[17]  Eun-So Lee,et al.  The vascular characteristics of melasma. , 2007, Journal of dermatological science.

[18]  S. Feldman,et al.  Melasma and its impact on health‐related quality of life in Hispanic women , 2007, The Journal of dermatological treatment.

[19]  Mi-Yeon Kim,et al.  Localized Intradermal Microinjection of Tranexamic Acid for Treatment of Melasma in Asian Patients: A Preliminary Clinical Trial , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  T. Hamilton,et al.  Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. , 1994, Archives of dermatology.

[21]  V. Mahajan,et al.  Weekly methotrexate versus daily isotretinoin to treat moderate-to-severe chronic plaque psoriasis: A comparative study , 2015 .

[22]  Zhu Hong.  The Clinical Study of Acidum Tranexamicum on Melasma , 2001 .

[23]  N. Higashi.  Treatment of Melasma with Oral Tranexamic Acid , 1988 .